Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19

Science(2021)10.1126/science.abf9302Source: DataRank Database

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19 is a research paper published in Science (2021). On theSindex it has a DataRank of 0. It has been cited 863 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access863 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 49.43)OA: hybridTopics (51)Linked Datasets (16)DataCite Reuse (16)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Allison J. Greaney ORCID,Amin Addetia ORCID,William W. Hannon ORCID,Manish C. Choudhary ORCID,Adam S. Dingens ORCID

Live enrichment

PubMed:33495308 PMC:PMC7963219 OpenAlex:https://openalex.org/W3125266951

Howard Hughes Medical Institute

Grant: Investigator

National Institute of Allergy and Infectious Diseases

Grant: R01AI127893

National Institute of Allergy and Infectious Diseases

Grant: R01AI141707

Bill and Melinda Gates Foundation

Grant: INV-004949

Damon Runyon Cancer Research Foundation

Grant: DRG-2381-19

Washington Research Foundation

Grant: Innovation Fellow

NIH HHS

Grant: S10 OD028685

NIAID NIH HHS

Grant: T32 AI083203

Howard Hughes Medical Institute

Massachusetts Consortium for Pathogen Readiness

Howard Hughes Medical Institute

FWCI

49.43

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1126/science.abf9302

publisherhttps://doi.org/10.1126/science.abf9302

publisherhttps://syndication.highwire.org/content/doi/10.1126/science.abf9302

publisherhttps://www.science.org/doi/pdf/10.1126/science.abf9302

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33495308

Fields of Study

SARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiologyViral Infections and Outbreaks ResearchAmino Acid SubstitutionAngiotensin-Converting Enzyme 2Antibodies, Monoclonal, HumanizedAntibodies, ViralCOVID-19Cells, CulturedDrug CombinationsHumansImmunization, PassiveMutationProtein BindingProtein DomainsReceptors, CoronavirusSARS-CoV-2Spike Glycoprotein, CoronavirusCOVID-19 SerotherapyAntibodies, Neutralizing

MeSH Terms

Protein DomainsReceptors, CoronavirusAngiotensin-Converting Enzyme 2COVID-19SARS-CoV-2COVID-19 SerotherapyAntibodies, ViralCells, CulturedDrug CombinationsHumansImmunization, PassiveMutationProtein BindingAmino Acid SubstitutionAntibodies, NeutralizingAntibodies, Monoclonal, HumanizedSpike Glycoprotein, Coronavirus

Keywords

Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyAntibodyBetacoronavirusCoronavirus InfectionsMutationBiologyGeneticsMedicineGeneInternal medicineOutbreak

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of A phenomics approach for antiviral drug discovery

10.6084/m9.figshare.15088503.v1figshare

Additional file 1 of A phenomics approach for antiviral drug discovery

10.6084/m9.figshare.15088503figshare

Additional file 2 of A phenomics approach for antiviral drug discovery

10.6084/m9.figshare.15088506.v1figshare

Additional file 2 of A phenomics approach for antiviral drug discovery

10.6084/m9.figshare.15088506figshare

Additional file 1 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815699figshare

Additional file 1 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815699.v1figshare

Additional file 1 of Antibody engineering improves neutralization activity against K417 spike mutant SARS-CoV-2 variants

10.6084/m9.figshare.19783635.v1figshare

Additional file 1 of Antibody engineering improves neutralization activity against K417 spike mutant SARS-CoV-2 variants

10.6084/m9.figshare.19783635figshare

Additional file 1 of Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron

10.6084/m9.figshare.26637489.v1figshare

10.6084/m9.figshare.26637489figshare

Additional file 4 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815708.v1figshare

Additional file 3 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815705figshare

Additional file 2 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815702figshare

Additional file 2 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815702.v1figshare

Additional file 4 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815708figshare

Additional file 3 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815705.v1figshare